Form 4: Ingredion Inc. President and CEO James P. Zallie Executes Stock Option and Sells Shares
SEC Form 4 Filing
James P. Zallie, President and CEO of Ingredion Inc., exercised stock options and sold 1,300 shares of common stock on August 28, 2024, according to a Form 4 filing with the SEC.
Summary
- On August 28, 2024, James P. Zallie, the President and CEO of Ingredion Inc., exercised employee stock options to acquire 1,300 shares of common stock at a price of $99.96 per share.
- Simultaneously, Zallie sold 1,300 shares of Ingredion Inc. common stock at a weighted average price of $134.025, with individual sales ranging from $134.000 to $134.035.
- Following these transactions, Zallie directly owns 52,530.1391 shares of Ingredion Inc. common stock.
- Zallie also directly owns 26,531 employee stock options.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing simply reports transactions by an insider under a pre-existing trading plan. There's no inherent positive or negative signal.
Positives
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, suggesting they were planned well in advance and not based on any immediate insider knowledge.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The sale of shares by the CEO could be interpreted in various ways, but the existence of a pre-arranged trading plan mitigates concerns about insider information.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
- Rule 10b5-1 trading plans are a common tool used by corporate insiders to manage their stock sales in compliance with insider trading laws.
- Comparing Zallie's stock ownership and trading activity to those of CEOs at comparable companies like Archer Daniels Midland (ADM) or Bunge (BG) could provide additional context.
Stakeholder Impact
- The sale of shares by the CEO could be perceived negatively by some shareholders, but the existence of a pre-arranged trading plan should reassure investors that the transactions were not based on any inside information.
Key Dates
| Date | Description |
|---|---|
| February 2, 2017 | First vesting date for employee stock options. |
| February 2, 2018 | Second vesting date for employee stock options. |
| February 2, 2019 | Third vesting date for employee stock options. |
| May 4, 2023 | Date of adoption of Rule 10b5-1 trading plan. |
| August 28, 2024 | Date of stock option exercise and stock sale. |
| August 29, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.